Literature DB >> 33246677

Surface plasmon resonance imaging-based biosensor for multiplex and ultrasensitive detection of NSCLC-associated exosomal miRNAs using DNA programmed heterostructure of Au-on-Ag.

Wenwen Wu1, Xiaolin Yu2, Jiangling Wu3, Tao Wu2, Yunpeng Fan1, Wenqin Chen1, Min Zhao1, Haiping Wu1, Xinmin Li4, Shijia Ding5.   

Abstract

Exosomal miRNAs are potential tumor biomarkers for early diagnosis of non-small cell lung cancer (NSCLC). Herein, a surface plasmon resonance imaging (SPRi)-based biosensor was developed for simultaneous detection of multiplex NSCLC-associated exosomal miRNAs in a clinical sample using Au-on-Ag heterostructure and DNA tetrahedral framework (DTF). Exosomal miRNAs are captured by various DTF probes immobilized on the gold array chip. Subsequently, single-stranded DNA (ssDNA) functionalized silver nanocube (AgNC) hybridizes with the captured exosomal miRNAs and then the ssDNA-coated Au nanoparticles assembled on the surface of AgNC, forming Au-on-Ag heterostructures as essential labels to realize amplified SPR response. With the aid of DNA programmed Au-on-Ag heterostructure and DTF, the SPRi-based biosensor exhibits wide detection range from 2 fM to 20 nM, ultralow limit of detection of 1.68 fM, enhanced capture efficiency, and improved antifouling capability. Furthermore, the biosensor enables accurate discrimination of NSCLC patients based on detection results of exosomal miRNAs. Overall, this developed biosensor is a promising tool for multiplex exosomal miRNAs detection, providing a new possibility for early diagnosis of NSCLC.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Exosomal miRNAs; Metal heterostructure; Multiplex detection; Non-small cell lung cancer; Surface plasmon resonance imaging

Mesh:

Substances:

Year:  2020        PMID: 33246677     DOI: 10.1016/j.bios.2020.112835

Source DB:  PubMed          Journal:  Biosens Bioelectron        ISSN: 0956-5663            Impact factor:   10.618


  8 in total

Review 1.  Pharmaceutical applications of framework nucleic acids.

Authors:  Liang Chen; Jie Zhang; Zhun Lin; Ziyan Zhang; Miao Mao; Jiacheng Wu; Qian Li; Yuanqing Zhang; Chunhai Fan
Journal:  Acta Pharm Sin B       Date:  2021-05-26       Impact factor: 11.413

Review 2.  Multiplexed Profiling of Extracellular Vesicles for Biomarker Development.

Authors:  Cheng Jiang; Ying Fu; Guozhen Liu; Bowen Shu; Jason Davis; George K Tofaris
Journal:  Nanomicro Lett       Date:  2021-12-02

Review 3.  Liquid Biopsy-Based Biosensors for MRD Detection and Treatment Monitoring in Non-Small Cell Lung Cancer (NSCLC).

Authors:  Parvaneh Sardarabadi; Amir Asri Kojabad; Davod Jafari; Cheng-Hsien Liu
Journal:  Biosensors (Basel)       Date:  2021-10-15

Review 4.  Exosomes as a new frontier of cancer liquid biopsy.

Authors:  Dan Yu; Yixin Li; Maoye Wang; Jianmei Gu; Wenrong Xu; Hui Cai; Xinjian Fang; Xu Zhang
Journal:  Mol Cancer       Date:  2022-02-18       Impact factor: 27.401

5.  In-Situ Monitoring the SERS Spectra of para-Aminothiophenol Adsorbed on Plasmon-Tunable Au@Ag Core-Shell Nanostars.

Authors:  Yan Ke; Bin Chen; Mengen Hu; Ningning Zhou; Zhulin Huang; Guowen Meng
Journal:  Nanomaterials (Basel)       Date:  2022-03-31       Impact factor: 5.076

Review 6.  The roles of small extracellular vesicles in cancer and immune regulation and translational potential in cancer therapy.

Authors:  Kewen Qian; Wenyan Fu; Tian Li; Jian Zhao; Changhai Lei; Shi Hu
Journal:  J Exp Clin Cancer Res       Date:  2022-09-27

7.  Screening for Potential Therapeutic Agents for Non-Small Cell Lung Cancer by Targeting Ferroptosis.

Authors:  Xin Zhao; Lijuan Cui; Yushan Zhang; Chao Guo; Lijiao Deng; Zhitong Wen; Zhihong Lu; Xiaoyuan Shi; Haojie Xing; Yunfeng Liu; Yi Zhang
Journal:  Front Mol Biosci       Date:  2022-07-14

8.  Surface plasmon resonance biosensor for exosome detection based on reformative tyramine signal amplification activated by molecular aptamer beacon.

Authors:  Wenqin Chen; Zhiyang Li; Wenqian Cheng; Tao Wu; Jia Li; Xinyu Li; Lin Liu; Huijie Bai; Shijia Ding; Xinmin Li; Xiaolin Yu
Journal:  J Nanobiotechnology       Date:  2021-12-24       Impact factor: 10.435

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.